InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Richardson Peter C, Directeur Médical. Director active across 2 companies, notably Antares Pharma, INC.. In total, 5 disclosures have been published. History available since 10 June 2021. The latest transaction was disclosed on 14 November 2023 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Peter C. Richardson is Executive Vice President and Chief Medical Officer at Antares Pharma, Inc. He is responsible for leading research and medical development, ensuring innovation and effectiveness of the company's products.